K A Ismailova

Pirogov Russian National Research Medical University, Moscow, Russia.

3 publications 2025 – 2025 ORCID

What does K A Ismailova research?

K A Ismailova studies how well a medication called Revelise (alteplase) works for patients who have experienced ischemic strokes, which are caused by blocked blood vessels in the brain. This researcher looks closely at the recovery outcomes of older patients and those with other health concerns after receiving this treatment. Their work aims to show how effectively this medication can reduce disabilities related to strokes and improve the quality of life for these patients over time.

Key findings

  • In a study involving 2,202 patients, nearly half (49.9%) achieved good recovery outcomes at discharge after receiving Revelise.
  • The percentage of patients with favorable outcomes increased to 66.4% after 90 days.
  • The research highlights that Revelise is effective for older patients and those with pre-existing health conditions, broadening its applicability.

Frequently asked questions

Does Dr. Ismailova study ischemic strokes?
Yes, Dr. Ismailova specifically studies treatments for ischemic strokes, focusing on the medication Revelise.
What treatments has Dr. Ismailova researched?
Dr. Ismailova has researched thrombolytic therapy using Revelise for treating ischemic stroke.
Is Dr. Ismailova's work relevant to older stroke patients?
Yes, Dr. Ismailova's research specifically includes older patients and shows that they can benefit from Revelise treatment.

Publications in plain English

[A clinical case of ischemic stroke in a patient with cardiac myxoma].

2025

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Khasanova LT, Arkhagova KN, Kazakova ZD, Okhtova DK, Ismailova KA +2 more

Plain English
The study looks at a patient who had a stroke caused by a rare heart tumor called a cardiac myxoma. Researchers found that using non-invasive imaging techniques, like echocardiograms, can help identify these tumors early, which is important because detecting and removing them can prevent future strokes. Cardiac myxomas are uncommon, affecting only about 0.03% of the general population, but their presence can lead to serious health issues like ischemic strokes. Who this helps: This helps patients with cardiac myxomas and doctors who treat heart-related conditions.

PubMed

[Cerebral venous thrombosis].

2025

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Iarovoi MD, Ismailova KA, Khasanova LT, Okhtova DK, Reznik EV

Plain English
This study looked at a condition called cerebral venous thrombosis, where blood clots form in the brain's veins and can lead to serious complications like strokes. The researchers presented a case of a patient who had a blood clot in a specific part of the brain due to a predisposition to clots, known as thrombophilia. Understanding this condition and its risk factors is important because it can help doctors better diagnose and treat patients who experience symptoms like headaches related to this serious issue. Who this helps: This helps doctors and patients at risk of blood clots in the brain.

PubMed

[Thrombolytic Therapy for Ischemic Stroke with Revelise: Results of a Two-Year Follow-Up in the International PRIMA Study].

2025

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Shamalov NA, Khasanova DR, Marchenko SV, Soldatov MA, Azarova AG +46 more

Plain English
This study looked at how well and safely Revelise (alteplase), a medication for treating ischemic stroke (IS), works in real-life situations. It involved 2,202 patients, mostly around 68 years old, and found that nearly half (49.9%) of them had good outcomes when discharged, rising to 66.4% after 90 days. The results showed that Revelise effectively reduces stroke-related disabilities, even in older patients and those with other health issues. Who this helps: This benefits patients who suffer from ischemic strokes and the doctors treating them.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.